Pfizer recalls anti-smoking drug due to high levels of ingredient tied increased risk of cancer
Published
Pfizer recalled its anti-smoking drug Chantix due to high levels of an ingredient that is tied to an increased risk of cancer.
Full ArticlePublished
Pfizer recalled its anti-smoking drug Chantix due to high levels of an ingredient that is tied to an increased risk of cancer.
Full ArticlePfizer is voluntarily recalling lots of its popular anti-smoking drug Chantix for high levels of nitrosamine, which can increase..